drugset / Trial / NCT02313155
Phase 1/2 Study of TAK-850 Subcutaneous Injection in Healthy Adults
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate the safety and immunogenicity of a single subcutaneous injection of TAK-850 as compared to intramuscular injection of TAK-850 in healthy Japanese adults
Timeline
- Start
- 2014-12
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TAK-850 | Vaccine | 0.5 ml | Subcutaneous |